AutoTSA
Build confidence in your drug target and speed up discovery with autoTSA, the fully automated platform for Target Safety Assessments (TSAs).
Powered by genAI and backed by nearly a decade of expertise in evidence-based risk ranking, autoTSA delivers:
- Comprehensive safety insights from the latest literature
- Highly accurate, prioritized risk assessments
- 1-day turnaround, even on data volumes no single researcher could process
We understand the challenges of moving from manual TSAs to automation. That’s why autoTSA keeps you in the loop. Verify every step, add your expert input and gain confidence in the results.
Ready to see the difference? Try your first TSA free and discover how cost-effective, fast and reliable automated safety assessment can be.
Contact us
-
Hidde Zittersteijn
Functie:Business Developer Biotech BoosterSpecialisatie niet bekendHidde joined the TNO Ventures team as a business developer as part of the Biotech Booster “Nationaal Groeifonds” project. Driven by the potential of (bio)technology to improve societal challenges, Hidde aims to use his background to help these innovations achieve their impact in society. Hidde previously worked as a PhD candidate at the Leiden University Medical Center and as Business developer at the Leiden Bio Science Park foundation.
-
E-mail:E-mail Hidde
-
LinkedIn:Hidde on LinkedIn
-